TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Arjo AB ( ($SE:ARJO.B) ) has provided an update.
Arjo’s incoming CEO, Andréas Elgaard, has acquired synthetic call options on the company’s shares, issued by its principal owner, Carl Bennet AB. This acquisition, valued at SEK 5 million, involves 1,184,834 options with a five-year term and is expected to align the CEO’s interests with the company’s performance, potentially impacting Arjo’s market positioning and stakeholder confidence.
The most recent analyst rating on ($SE:ARJO.B) stock is a Hold with a SEK36.00 price target. To see the full list of analyst forecasts on Arjo AB stock, see the SE:ARJO.B Stock Forecast page.
More about Arjo AB
Arjo is a company focused on empowering movement within healthcare environments to ensure quality care. Their products and solutions include patient handling, medical beds, personal hygiene, disinfection, diagnostics, and prevention of pressure injuries and venous thromboembolism. With over 7,000 employees worldwide and more than 65 years of experience, Arjo is dedicated to improving outcomes for individuals with mobility challenges.
YTD Price Performance: -0.78%
Average Trading Volume: 641,455
Technical Sentiment Signal: Sell
Current Market Cap: SEK9.51B
See more insights into ARJO.B stock on TipRanks’ Stock Analysis page.